CompletedNot Applicable

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

Iran169 participantsStarted 2022-09-03

Plain-language summary

This study aimed to compare the long-term efficacy and safety of levetiracetam and valproate in treatment of idiopathic generalized epilepsy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of juvenile myoclonic epilepsy or generalized tonic-clonic seizure alone * Regular monotherapy with levetiracetam or sodium valproate Exclusion Criteria: * Poor drug adherence * Pregnancy

What they're measuring

Seizure free rate

Timeframe: 1 to 5 years

Time to first seizure

Timeframe: 1 to 5 years

Trial details

NCT IDNCT06393309

SponsorMazandaran University of Medical Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-19

View on ClinicalTrials.gov More Treatment of Idiopathic Generalized Epilepsy trials